Anteris Technologies Ltd.
Nasdaq AVR · Eagan, MN
Works in Cardiovascular
Anteris Technologies Ltd. is a clinical trial sponsor based in Eagan, MN, listed as Nasdaq AVR. It has 4 active clinical trials with 1,830 planned participants, in Cardiovascular.
Trial track record · since 2021
Financials · Nasdaq AVR
Fundraising
Pipeline · 4 active trials
| Stage | Trial | Status |
|---|---|---|
Questions about Anteris Technologies Ltd
Anteris Technologies Ltd is lead sponsor of 4 active clinical trials on ClinicalTrials.gov, with 1,830 planned participants, in Cardiovascular. Since 2021 it has completed 0 trials and stopped 0 early.
Anteris Technologies Ltd is based in Eagan, MN and is listed as Nasdaq AVR. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Anteris Technologies Ltd; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-09-16.
Approve Suite is not affiliated with Anteris Technologies Ltd..
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.